WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ: RGEN) announced today that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will present a corporate update at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012 at 2 p.m. EST at the Waldorf Astoria in New York City.
